Abiopharma

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206607 <b>Size:</b> 1 MB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206609 <b>Size:</b> 290 KB

New Form DEFA14A - Strategy Inc <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206606 <b>Size:</b> 487 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001213900-26-052255 <b>Size:</b> 2 MB

New Form SCHEDULE 13D - Genenta Science S.p.A. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001493152-26-021319 <b>Size:</b> 133 KB

New Form SCHEDULE 13G - Irenic Acquisition Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001104659-26-055685 <b>Size:</b> 15 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206599 <b>Size:</b> 775 KB

New Form DEF 14A - Range Capital Acquisition Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206596 <b>Size:</b> 895 KB

New Form 3 - Pasithea Therapeutics Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001213900-26-052254 <b>Size:</b> 3 KB

New Form SCHEDULE 13D/A - MFS HIGH YIELD MUNICIPAL TRUST <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001398344-26-008398 <b>Size:</b> 10 KB

Director Babcock Beverley A 🟢 acquired 7.0K shares (1 derivative) of OLIN Corp (OLN) at $28.48 Transaction Date: May 01, 2026 | Filing ID: 000002

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001193125-26-206593 <b>Size:</b> 416 KB

TCOM 6-DAY DEADLINE ALERT: Trip.com (TCOM) Facing Securities Class Action After AI Pricing Controversy and Anti-Monopoly Probe Sends Shares Tumbling -- Hagens Berman

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001839882-26-023072 <b>Size:</b> 375 KB